About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Alembic Pharmaceuticals Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
533573
ISIN Demat
INE901L01018
Book Value
255.98
NSE Code
APLLTD
Dividend Yield %
1.04
Market Cap
207374.10
P/E
26.69
EPS
39.53
Face Value
2
BSE
NSE
20-Dec-2024
BSE
NSE
NSE F & O
20-Dec-2024
BSE
NSE
NSE F & O
Last Price
1055.00
Net Change
4.85
% Change
0.46%
Prev.Close
1050.15
Open
1047.00
High
1081.10
Low
1047.00
Volume
7304
Last Price
1055.15
Net Change
7.35
% Change
0.7%
Prev.Close
1047.80
Open
1047.80
High
1081.90
Low
1046.50
Volume
304458
Value
7753150
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
1081.10
52-Week High
1296.15
52-Week Low
744.95
Value
323050247
Best Buy
0.00
Best Sell
1055.15
Best Quantity
0
Sell Quantity
133
Today's Range
1081.90
52-Week High
1303.90
52-Week Low
746.00
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
133
Price
1055.15
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
21-Jul-21
27-Jul-21
Dividend
550 %
15-Jul-24
Company News
20-12-2024
Alembic Pharmaceuticals g...
11-12-2024
Alembic Pharmaceuticals c...
11-12-2024
Alembic Pharmaceuticals i...
04-12-2024
Alembic Pharma gets USFDA...
02-12-2024
Alembic Pharmaceuticals i...
25-11-2024
USFDA completes inspectio...
12-11-2024
Alembic Pharma gets USFDA...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.